# A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

> **NCT00048204** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 372 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** GW597599B
- **DRUG:** paroxetine

## Key facts

- **NCT ID:** NCT00048204
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-11-04
- **Primary completion:** 2003-09-30
- **Final completion:** 2003-09-30
- **Target enrollment:** 372 (ACTUAL)
- **Last updated:** 2017-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048204, "A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00048204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*